The GLP-1 Ripple Effect: How Obesity Drugs Are Reshaping Logistics, Healthcare, and Supply Chains artwork

The GLP-1 Ripple Effect: How Obesity Drugs Are Reshaping Logistics, Healthcare, and Supply Chains

InvestTalk

August 4, 2026

The explosive growth of GLP-1 obesity drugs is creating a massive cold storage logistics boom, with FedEx, UPS, and DHL racing to build out healthcare supply chain capacity in a market they can't afford to miss.
Speakers: Justin Klein, Luke Guerrero
**SPEAKER_1** (0:01)
This is InvestTalk from KPP Financial, helping investors make sense of the markets one day at a time. And now, here are Justin Klein and Luke Guerrero.

**Justin Klein** (0:15)
Good afternoon, fellow investors, and welcome back to InvestTalk. This is our August 3rd, 2026 edition of InvestTalk, and we have a special episode. Not only is it the first episode of the month of August, can't believe it's already August, but I also have Luke with me today. We don't often do the show together, but hey, it's a good way to ring in the month of August, right?

**Luke Guerrero** (0:42)
Yeah, good way to start getting deeper into the second half of the year.

**Justin Klein** (0:47)
Deeper, much deeper. We're now a full month through the second half of the year, through the third quarter, and a lot to unpack on this show.
We have a lot going on geopolitically, economically, within sectors of the market, different asset classes, so a lot to dig into this hour. And we're going to mainly do that by answering your finance and investment questions. We want to know what is on your mind. 888.99 chart is how you get through and ask your question on the show each and every weekday. We're also going to bring you topics and our own perspectives to help you make better decisions with your money, but ultimately, this hour is for you. So you drive the show and I encourage you to pick up the phone and give us a call. Now in just a bit, we'll talk about today's Marke performance and run down the show topics. But first, let's tackle this caller question now.

**SPEAKER_4** (1:41)
Hey guys, had a question. This is Chris in South Carolina. I own a small, very small position in Comcast. I believe it's Cmcsa.
I'd like to see what you guys think about it. I'm ahead of the game a little bit. Wanted to know maybe I should get in a little more or get out. Comcast, thanks for your help. I'll be listening.

**Justin Klein** (2:03)
Are looking at Comcast, Cmcsa, one of the largest cable providers, internet providers in the country. Marked up about $85 billion. Has a good yield, Luke, 5.3% dividend yield, but it's fairly low growth. Earnings back in 2022 were $3.41. This year is supposed to be $3.51 and $3.62 next year.
A slow growth business, revenue is supposed to be on 2% this year and next year. Is it worth that yield?

**Luke Guerrero** (2:44)
Well, we talk about this all the time, especially for people that tend to focus on yield as a primary concern, I would say.
Unfortunately, they're doing that. I don't think that's the best way to go about building a portfolio, but what you see is, okay, that 5% yield sounds nice, but in the past three years, it's been negative 14% in terms of price return, negative 20, this year down 12.3. So although the yield is positive, the total return has still been negative over that period of time. Now, this is a name that we, for some time, have been watching. It's been something that we wanted to add to one of our strategies, but haven't really seen kind of the turnaround both from a fundamental perspective and from a momentum perspective as well that would indicate wanting to enter a full position.

**Justin Klein** (3:32)
Yeah, I think it's still TBD. It looks like it is finding a bottom though. If you look at kind of the recent volatility, it's been it's been hanging around here around the mid-20s mark for a while. Nice little another updated day about 2.5%.
The biggest question is that debt. They do have a lot of debt about $80 billion in net debt on their balance sheet, but good cash flow, free cash flow, about $17.8 billion. So the question is, can they continue to produce that level of cash flow and whittle down the amount of debt outstanding? It has gone. At the end of last year, Luke, did $104 billion in long-term debt. Now we're down to 90 in just half a year. So they've done a good job so far. We'll see if they could continue. I think from a valuation standpoint, enterprise value even is right around five. As long as that cash flow stays around these levels or improves, I think they can get their balance sheet back in order, continue to pay that dividend yield, and maybe even raise their dividend. What was the last time they raised their dividend? Let's see this. Actually, they continue to raise their dividend. So they feel pretty confident in this balance sheet that they've been raising their dividend pretty much every year for the past decade plus.

34 more minutes of transcript below

Feed this to your agent

Try it now — copy, paste, done:

curl -H "x-api-key: pt_demo" \
  https://spoken.md/transcripts/1000651996090

Works with Claude, ChatGPT, Cursor, and any agent that makes HTTP calls.

From $0.10 per transcript. No subscription. Credits never expire.

Using your own key:

curl -H "x-api-key: YOUR_KEY" \
  https://spoken.md/transcripts/YOUR_EPISODE_ID